Analytical Data
-
Gene name
IFNAR1
- Application
-
Alternative Names
IFNAR1; AVP; IFN-alpha-REC; IFNAR; IFNBR; IFRC; Interferon-Alpha, Beta And Omega Receptor Alpha Chain; Cytokine receptor family 2 member 1
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
D3ZDS9
-
Expression Region
Val244~Arg512
-
Molecular Weight
33kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IFNAR1, the Interferon-Alpha/Beta Receptor 1, is a critical component of the immune response and plays a pivotal role in the signaling pathways activated by type I interferons (IFN-I). These cytokines are vital for the host defense against viral infections and in modulating immune responses. Research into IFNAR1 recombinant proteins has gained momentum due to their potential applications in therapeutic interventions for viral diseases, autoimmune disorders, and cancer. Understanding the molecular mechanisms of IFNAR1 signaling helps elucidate how cells respond to viral pathogens and contribute to establishing an antiviral state. Additionally, IFNAR1 has been implicated in various diseases, making it a target for drug development. Recombinant IFNAR1 proteins can also serve as valuable tools for studying receptor interactions and signaling pathways, potentially leading to the identification of novel therapeutic strategies. Moreover, as the demand for effective biotherapeutics rises, characterizing and optimizing the production of IFNAR1 recombinant proteins is crucial for advancing research and clinical applications in immunology.
